Close Menu

CHARLOTTE, NC (GenomeWeb) — Laboratories with clinically validated next-gen sequencing assays are having trouble detecting certain complex variants, according to a recent interlaboratory study led by researchers at Invitae, suggesting that better standards are needed to ensure the quality of NGS-based genetic testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.